Three executive leaders describe how they see Huntsman Cancer Institute advancing cancer care and research in 2025 and beyond, including increasing cancer care access for all.
Utah TV icon Bill Gephardt says “shared decision making,” a process where specialists help patients pick the best treatment option, empowered him during his prostate cancer treatment.
The latest advances in cancer research from Huntsman Cancer Institute include a new prostate cancer treatment, a method to predict aggressive breast cancer, and microbiome links to melanoma immunotherapy response.
A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved overall survival rates for metastatic prostate cancer compared to standard treatments.
From a broken faucet to a cancer diagnosis, Brock O'Neil, MD, urologic surgeon-scientist at Huntsman Cancer Institute, shares his journey to academic medicine and cancer care.
Explore prostate cancer treatment options like surgery, radiation, and hormone therapy. Learn how to choose the best approach with your healthcare provider’s guidance and support.
The chance of getting prostate cancer increases with age, but genetics can also be a risk factor. Huntsman Cancer Institute genetic counselor Sam Beck answers questions about prostate cancer.
Highlights from Huntsman Cancer Institute’s latest studies reveal elevated ovarian cancer risk in women with endometriosis and highlight challenges in bladder cancer treatment and insurance access for childhood cancer survivors.
A virtual support group provides a way for members to openly share struggles, find emotional support, and learn coping techniques from experts, creating a unique brotherhood.
Landmark survey illustrates the care barriers that rural and frontier communities face throughout the Mountain West. This groundbreaking work helps Huntsman Cancer Institute address these disparities more effectively.
Heloisa Soares, MD, PhD, and Skyler Johnson, MD, were selected as members of The Society of Huntsman Translational Scholars for their contributions to advancing cancer research and patient care.
PJ DiPentino made the seven-hour trek from his home in Montana to Huntsman Cancer Institute. After receiving a warm welcome, he underwent bladder surgery and left with a long-lasting connection.
Three-year-old Parker Felton underwent a difficult 40-week regimen of surgery, chemotherapy, and radiation. Now, she’s cancer free and ready to get back to being a kid.
Prevention leaders convened at Huntsman Cancer Institute for the Mountain West HPV Stakeholder Meeting, to discuss ways to eliminate related cancers through collaboration, research, and innovative strategies.
From shrinking brain tumors to personalized therapies, our investigators are leading pioneering research, discovering breakthroughs in treatment, and promoting equity-driven care.
